EDUCATION 2000.9--2004.6 Pharmacy College of Jilin University Bachelor's Degree, Major: Pharmacy 2006.9--2009.6 Pharmacy College of Lanzhou University Master's degree， Major: Tumor Pharmacology  2013.9-- Xi`an Jiaotong University Health Science Center Major: Pharmacology  WORKING EXPERIENCE 2004.7--2006.8 Jilin Yatai Biopharmaceutical Co.,LTD Technician 2009.7--2011.4 Qizheng Tibetan Medicine. Pharmacology researcher 2011.5- Shaanxi Liposome Research Centre. New Drug Project Manager ARTICLE 1.Wu-dang Lu, Min-quan Hui, Tao Chen, Sheng Wang, Qing-qing Li, Lei Cao and Yong-xiao Cao. The Pharmacokinetics and Analgesic Effect of Ropivacaine Oil Solu- tion after Subcutaneous Injection to Mini-Pig Operative Incision. United Journal of Pharmacology and Therapeutics.2018.1(1): 1-10. 2.Min-Quan Hui, Wu-Dang Lu, Wei-Ping Yu, Tao Chen, Jing-Liang Gu and Yong- Xiao Cao. Pharmacokinetics and Toxicity of Oily Delivery System of Ropivacaine via Subcutaneous Injection in Beagle Dogs. J. Pharmacol. Toxicol., 2018.13 (1): 37-44. 3.Lu Wu-dang, Ma Shu-mei, Wei Dong, Chen Yao, Fu Jing-guo, Liu Li. Effect of carboxymethyl starch sodium solution on the immune suppression induced by dexamethasone in immature mice. World Clinical Drugs. 2019.40(9): 613-617[doi: 10.13683/j.wph.2019.09.004]. 4.Wu-dang Lu, Zi-cheng Li, Ming-tang Gao, Yong-jie Wu, Wen-guang Li. Chronic toxicity of Escherichia coli O157:H7 polysaccharide-conjugated vaccine in rats immunized intramuscularly. China Pharmacy 2009.20 (31): 2410-2413. 5.Ma Yan Chen Tao Lu Wu-dang Zhao Ni Li Fei. Detection of Degradation Impurities in Different Solvents of Suxamethonium Chloride Injection. China Pharmaceuticals 2019,28 (11),53-55. [Doi:10.3969/j.issn.1006-4931.2019.11.016] . 6.Wu Man-li; Huang Ting-ting; Du Shuai-shuai; Lu Wu-dang; Cao Yong-xiao Effect of sodium carboxymethyl starch on constipation in mice[J]. Journal of Xian Jiaotong University(Medical Sciences),2020,41(1):79-83.[doi:10.7652/jdyxb202001015] PATENT 1.Lu Wu-dang, Yu Wei-ping, Chen Tao, et al. Formulation and preparation method of non-addictive drug delivery system for analgesia. Application No. : CN201310022657 (authorization: 2015.9). 2.Lu Wu-dang, YU Wei-ping, Chen Tao, et al. A kind of flavistry group or its derivatives oily preparation and its preparation method. Application No. : CN201210092901 (authorization: 2014.8). 3.Lu Wu-dang, YU Wei-ping, Chen Tao, et al. Oily preparations of Flavistry group or its derivatives based on lactic acid ester and their preparation methods. Application No. : CN201210093205 (authorization: 2014.1). 4.Yu Weiping, LU Wu-dang, Chen Tao, et al. Suspension preparation of temperature-modified painless nano sulfadiazine metal compound hyaluronic acid. Application No. : CN201410183638 (authorization: 2017.4). 5.Lu Wu-dang, YU Wei-ping, Chen Tao, et al. Sustained-release preparations of Flavistry group or its derivatives and their preparation methods. Application No. : CN201210092724. 6.Lu Wu-dang, LI Qingqing, Chen Tao et al. Formulation and application of a compound slow-release drug delivery system for long-term analgesia and wound healing. Application No. : CN201811346227. 7.Lu Wudang, Liang Na, Chen Tao et al. Formulation and preparation method of phospholipid-Solution-oil sustained-release delivery system for local anesthetics. Application No. : CN201810592597. 8.Chen Tao, GU Jian-yin, Lu Wu-dang, et al. Long-acting delivery system for the treatment of breast cancer, its preparation method and application. Application Number: CN201810007971. NEW DRUG APPROVAL DOCUMENTS Long-acting Ropivacaine injection, new drug(505B2), clinical approval, approval Number: 2017L00490. AWARD 1. Industrialization of painless new alprotier fat emulsion. Xi 'an Science and Technology Award, first class; 2. Long-acting Ropivacaine injection (ropivacaine oil delivery Reservoir). 2016 China (Chengdu) Overseas Talent Innovation and Entrepreneurship Project Competition, Class 2. PROJECT 1. Research and development of the national new drug "succinylcholine chloride API and its preparations", involving 0.46 million; 2. Research and development and application of biodegradable hemostatic materials containing anti-tumor active components, participated in, and applied for 1 million.